Literature DB >> 22432504

A comparison of ejaculated and testicular spermatozoa aneuploidy rates in patients with high sperm DNA damage.

Sergey I Moskovtsev1, Naazish Alladin, Kirk C Lo, Keith Jarvi, J Brendan M Mullen, Clifford L Librach.   

Abstract

Testicular spermatozoa are utilized to achieve pregnancy in couples with severe male factor infertility. Several studies suggest that aneuploidy rates in spermatozoa are elevated at the testicular level in infertile patients compared to ejaculates of normal controls. However, essential data regarding aneuploidy rates between ejaculated and testicular spermatozoa in the same individuals is lacking. The purpose of our study was to compare aneuploidy rates at the testicular and post-testicular level from the same patients with persistently high sperm DNA damage. Ejaculates and testicular biopsies were obtained from eight patients with persistently high DNA damage (>30%). Both ejaculated and testicular samples were analyzed for sperm DNA damage and sperm aneuploidy for chromosomes 13, 18, 21, X, and Y. In addition, semen samples from ten normozoospermic men presenting for fertility evaluation served as a control group. A strong correlation between the alteration of spermatogenesis and chromatin deterioration was observed in our study. In the same individuals, testicular samples showed a significantly lower DNA damage compared to ejaculated spermatozoa (14.9% ± 5.0 vs. 40.6% ± 14.8, P<0.05), but significantly higher aneuploidy rates for the five analyzed chromosomes (12.41% ± 3.7 vs. 5.77% ± 1.2, P<0.05). While testicular spermatozoa appear favourable for ICSI in terms of lower DNA damage, this potential advantage could be offset by the higher aneuploidy rates in testicular spermatozoa.

Entities:  

Mesh:

Year:  2012        PMID: 22432504     DOI: 10.3109/19396368.2012.667504

Source DB:  PubMed          Journal:  Syst Biol Reprod Med        ISSN: 1939-6368            Impact factor:   3.061


  20 in total

1.  Fluorescent in situ hybridization of human sperm: diagnostics, indications, and therapeutic implications.

Authors:  Ranjith Ramasamy; Stefan Besada; Dolores J Lamb
Journal:  Fertil Steril       Date:  2014-10-22       Impact factor: 7.329

2.  Switching to testicular sperm after a previous ICSI failure with ejaculated sperm significantly improves blastocyst quality without increasing aneuploidy risk.

Authors:  Irene Hervas; Maria Gil Julia; Rocío Rivera-Egea; Ana Navarro-Gomezlechon; Laura Mossetti; Nicolás Garrido
Journal:  J Assist Reprod Genet       Date:  2022-08-16       Impact factor: 3.357

Review 3.  Sperm retrieval techniques.

Authors:  Daniel H Shin; Paul J Turek
Journal:  Nat Rev Urol       Date:  2013-12-03       Impact factor: 14.432

Review 4.  Sperm DNA fragmentation testing: Summary evidence and clinical practice recommendations.

Authors:  Sandro C Esteves; Armand Zini; Robert Matthew Coward; Donald P Evenson; Jaime Gosálvez; Sheena E M Lewis; Rakesh Sharma; Peter Humaidan
Journal:  Andrologia       Date:  2020-10-27       Impact factor: 2.775

Review 5.  The Use of Testicular Sperm for Intracytoplasmic Sperm Injection in Patients with High Sperm DNA Damage: A Systematic Review.

Authors:  Rafael F Ambar; Ashok Agarwal; Ahmad Majzoub; Sarah Vij; Nicholas N Tadros; Chak Lam Cho; Neel Parekh; Edson Borges; Sidney Glina
Journal:  World J Mens Health       Date:  2020-06-25       Impact factor: 5.400

Review 6.  Effects of increased paternal age on sperm quality, reproductive outcome and associated epigenetic risks to offspring.

Authors:  Rakesh Sharma; Ashok Agarwal; Vikram K Rohra; Mourad Assidi; Muhammad Abu-Elmagd; Rola F Turki
Journal:  Reprod Biol Endocrinol       Date:  2015-04-19       Impact factor: 5.211

Review 7.  Use of testicular sperm for intracytoplasmic sperm injection in men with high sperm DNA fragmentation: a SWOT analysis.

Authors:  Sandro C Esteves; Matheus Roque; Nicolás Garrido
Journal:  Asian J Androl       Date:  2018 Jan-Feb       Impact factor: 3.285

8.  Finding the fit: sperm DNA integrity testing for male infertility.

Authors:  Paul J Turek
Journal:  Transl Androl Urol       Date:  2017-09

9.  More good than harm should be expected when Testi-ICSI is applied to oligozoospermic men with post-testicular sperm DNA fragmentation.

Authors:  Sandro C Esteves; Ahmad Majzoub; Ashok Agarwal
Journal:  Transl Androl Urol       Date:  2017-09

10.  Is National Institute of Clinical Excellence (NICE) guideline a nice guideline?

Authors:  Ashok Agarwal; Chak-Lam Cho; Ahmad Majzoub; Sandro C Esteves
Journal:  Transl Androl Urol       Date:  2017-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.